Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 2
2003 1
2004 1
2006 1
2007 1
2008 1
2009 1
2013 2
2014 2
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
A Deep Learning-Based Automated CT Segmentation of Prostate Cancer Anatomy for Radiation Therapy Planning-A Retrospective Multicenter Study.
Kiljunen T, Akram S, Niemelä J, Löyttyniemi E, Seppälä J, Heikkilä J, Vuolukka K, Kääriäinen OS, Heikkilä VP, Lehtiö K, Nikkinen J, Gershkevitsh E, Borkvel A, Adamson M, Zolotuhhin D, Kolk K, Pang EPP, Tuan JKL, Master Z, Chua MLK, Joensuu T, Kononen J, Myllykangas M, Riener M, Mokka M, Keyriläinen J. Kiljunen T, et al. Among authors: lehtio k. Diagnostics (Basel). 2020 Nov 17;10(11):959. doi: 10.3390/diagnostics10110959. Diagnostics (Basel). 2020. PMID: 33212793 Free PMC article.
Imaging of tumor hypoxia to predict treatment sensitivity.
Minn H, Grönroos TJ, Komar G, Eskola O, Lehtiö K, Tuomela J, Seppänen M, Solin O. Minn H, et al. Among authors: lehtio k. Curr Pharm Des. 2008;14(28):2932-42. doi: 10.2174/138161208786404380. Curr Pharm Des. 2008. PMID: 18991711 Review.
In vivo imaging of prostate cancer using [68Ga]-labeled bombesin analog BAY86-7548.
Kähkönen E, Jambor I, Kemppainen J, Lehtiö K, Grönroos TJ, Kuisma A, Luoto P, Sipilä HJ, Tolvanen T, Alanen K, Silén J, Kallajoki M, Roivainen A, Schäfer N, Schibli R, Dragic M, Johayem A, Valencia R, Borkowski S, Minn H. Kähkönen E, et al. Among authors: lehtio k. Clin Cancer Res. 2013 Oct 1;19(19):5434-43. doi: 10.1158/1078-0432.CCR-12-3490. Epub 2013 Aug 9. Clin Cancer Res. 2013. PMID: 23935037 Free article.
Plasma pharmacokinetics, whole-body distribution, metabolism, and radiation dosimetry of 68Ga bombesin antagonist BAY 86-7548 in healthy men.
Roivainen A, Kähkönen E, Luoto P, Borkowski S, Hofmann B, Jambor I, Lehtiö K, Rantala T, Rottmann A, Sipilä H, Sparks R, Suilamo S, Tolvanen T, Valencia R, Minn H. Roivainen A, et al. Among authors: lehtio k. J Nucl Med. 2013 Jun;54(6):867-72. doi: 10.2967/jnumed.112.114082. Epub 2013 Apr 5. J Nucl Med. 2013. PMID: 23564761 Free article. Clinical Trial.
Pharmacokinetics of [18F]FETNIM: a potential marker for PET.
Grönroos T, Eskola O, Lehtiö K, Minn H, Marjamäki P, Bergman J, Haaparanta M, Forsback S, Solin O. Grönroos T, et al. Among authors: lehtio k. J Nucl Med. 2001 Sep;42(9):1397-404. J Nucl Med. 2001. PMID: 11535732 Free article.
Prognostic value of tumour blood flow, [¹⁸F]EF5 and [¹⁸F]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy.
Komar G, Lehtiö K, Seppänen M, Eskola O, Levola H, Lindholm P, Sipilä H, Seppälä J, Grénman R, Solin O, Minn H. Komar G, et al. Among authors: lehtio k. Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2042-50. doi: 10.1007/s00259-014-2818-3. Epub 2014 Jun 5. Eur J Nucl Med Mol Imaging. 2014. PMID: 24898846
13 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page